In vivo and vitro study showed that hypomethylation of Ribonuclease 6 promoter aggravates atherosclerosis in mice, enhances proliferation and migration of oxLDL treated murine aortic VSMCs, and upregulated ROS content and inflammatory factor secretion levels in the cells [53]. Here, RNASET2 is linked to atherosclerosis.